79605009: 3 (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
3	Is a	General adjectival modifier	false	Inferred relationship	Some
3	Is a	Number	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely budesonide 3 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Bromazepam 3 mg oral tablet	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Auranofin 3 mg oral tablet	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Hydromorphone hydrochloride 3 mg oral tablet	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Auranofin 3 mg oral capsule	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Warfarin sodium 3 mg oral tablet	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Risperidone 3 mg oral tablet	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Rivastigmine (as rivastigmine tartrate) 3 mg oral capsule	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Oxybutynin hydrochloride 3 mg oral tablet	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Ivermectin 3 mg oral tablet	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Product containing precisely ropinirole hydrochloride 3 milligram/1 each conventional release oral tablet	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 3 milligram/1 each conventional release oral capsule	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Product containing precisely pomalidomide 3 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Product containing precisely flupentixol 3 milligram/1 each conventional release oral tablet	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Glimepiride 3 mg oral tablet	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Glibenclamide micronised 3 mg oral tablet	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Estropipate 3 mg oral tablet	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	False	3	Inferred relationship	Some	2
Product containing only ethinylestradiol 0.03 milligram and drospirenone 3 milligram/1 each oral tablet	Has presentation strength numerator value	False	3	Inferred relationship	Some	2
Eszopiclone 3 mg oral tablet	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Doxepin 3 mg oral tablet	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Dinoprostone 3 mg vaginal tablet	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Product containing precisely apomorphine hydrochloride 3 milligram/1 each conventional release sublingual tablet (clinical drug)	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Product containing precisely budesonide 3 milligram/1 each gastro-resistant oral capsule (clinical drug)	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Product containing precisely prochlorperazine maleate 3 milligram/1 each conventional release buccal tablet (clinical drug)	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely ascorbic acid 10 milligram and ferrous gluconate 250 milligram and folic acid 5 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	3	Inferred relationship	Some
Caffeine 15 mg and codeine phosphate 15 mg and paracetamol 300 mg oral tablet	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely aspirin 250 milligram and caffeine 65 milligram and paracetamol 250 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely amiloride hydrochloride 2.5 milligram and atenolol 50 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	3	Inferred relationship	Some
Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely abacavir 300 milligram and lamivudine 150 milligram and zidovudine 300 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	3	Inferred relationship	Some
Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	3	Inferred relationship	Some
Ascorbic acid 60 mg and cyanocobalamin 5 mg and ferrous fumarate 200 mg oral capsule	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	3	Inferred relationship	Some
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	3	Inferred relationship	Some
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet	Count of base of active ingredient	False	3	Inferred relationship	Some
Caffeine 15 mg and codeine phosphate 30 mg and paracetamol 300 mg oral tablet	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram and timolol maleate 10 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	3	Inferred relationship	Some
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet	Count of base of active ingredient	False	3	Inferred relationship	Some
Aspirin 770 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	3	Inferred relationship	Some
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule	Count of base of active ingredient	False	3	Inferred relationship	Some
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	3	Inferred relationship	Some
Ethinylestradiol 30 microgram and ferrous fumarate 75 mg and norgestrel 300 microgram oral tablet	Count of base of active ingredient	False	3	Inferred relationship	Some
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	3	Inferred relationship	Some
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet	Count of base of active ingredient	False	3	Inferred relationship	Some
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet	Count of base of active ingredient	False	3	Inferred relationship	Some
Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet	Count of base of active ingredient	False	3	Inferred relationship	Some
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet	Count of base of active ingredient	False	3	Inferred relationship	Some
Product containing precisely ceftazidime (as ceftazidime pentahydrate) 3 gram/1 vial powder for conventional release solution for injection	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Cetrorelix (as cetrorelix acetate) 3 mg powder for solution for injection vial	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Product containing precisely triptorelin (as triptorelin acetate) 3 milligram/1 vial powder for conventional release suspension for injection (clinical drug)	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Product containing precisely potassium aminobenzoate 3 gram/1 sachet powder for conventional release oral solution (clinical drug)	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Product containing precisely codeine phosphate 3 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength numerator value	False	3	Inferred relationship	Some	1
Prednisolone 3 mg/mL oral solution	Has concentration strength numerator value	False	3	Inferred relationship	Some	1
Product containing precisely phenobarbital 3 milligram/1 milliliter conventional release oral elixir (clinical drug)	Has concentration strength numerator value	False	3	Inferred relationship	Some	1
Product containing precisely prednisolone 3 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has concentration strength numerator value	False	3	Inferred relationship	Some	1
Ephedrine hydrochloride 3 mg/mL oral solution	Has concentration strength numerator value	False	3	Inferred relationship	Some	1
Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter conventional release solution for ear or eye drops	Has concentration strength numerator value	False	3	Inferred relationship	Some	1
Product containing precisely coal tar 10 milligram/1 gram and dithranol 1.1 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous ointment (clinical drug)	Count of base of active ingredient	False	3	Inferred relationship	Some
Hydroxypropyl methylcellulose 0.32% conventional release eye drops	Has concentration strength numerator value	False	3	Inferred relationship	Some	1
Hypromellose 3 mg/mL eye drops	Has concentration strength numerator value	False	3	Inferred relationship	Some	1
Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug)	Count of base of active ingredient	False	3	Inferred relationship	Some
Diflucortolone valerate 3 mg/g cutaneous ointment	Has concentration strength numerator value	False	3	Inferred relationship	Some	1
Product containing precisely calcitriol 3 microgram/1 gram conventional release cutaneous ointment (clinical drug)	Has concentration strength numerator value	False	3	Inferred relationship	Some	1
Heparinoid 3 mg/g cutaneous cream	Has concentration strength numerator value	False	3	Inferred relationship	Some	1
Product containing precisely heparinoid 3 milligram/1 gram conventional release cutaneous gel (clinical drug)	Has concentration strength numerator value	False	3	Inferred relationship	Some	1
Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter and hydrocortisone acetate 10 milligram/1 milliliter conventional release ear drops (clinical drug)	Has concentration strength numerator value	False	3	Inferred relationship	Some	2
Diflucortolone valerate 3 mg/g cutaneous cream	Has concentration strength numerator value	False	3	Inferred relationship	Some	1
Product containing precisely ofloxacin 3 milligram/1 milliliter conventional release eye drops (clinical drug)	Has concentration strength numerator value	False	3	Inferred relationship	Some	1
Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL eye drops	Has concentration strength numerator value	False	3	Inferred relationship	Some	1
Dexamethasone 1 mg/mL and tobramycin 3 mg/mL eye drops	Has concentration strength numerator value	False	3	Inferred relationship	Some	1
Product containing precisely disodium pamidronate 60 milligram/20 milliliter conventional release solution for injection vial	Has concentration strength numerator value	False	3	Inferred relationship	Some	1
Product containing precisely disodium pamidronate 90 milligram/30 milliliter conventional release solution for injection vial	Has concentration strength numerator value	False	3	Inferred relationship	Some	1
Product containing precisely ephedrine hydrochloride 30 milligram/10 milliliter conventional release solution for injection ampule	Has concentration strength numerator value	False	3	Inferred relationship	Some	1
Product containing precisely clavulanic acid (as clavulanate potassium) 200 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength numerator value	False	3	Inferred relationship	Some	1
Cetrimide 3 mg/g and dimeticone 1000 100 mg/g cutaneous cream	Has concentration strength numerator value	False	3	Inferred relationship	Some	2
Product containing precisely adenosine 30 milligram/10 milliliter conventional release solution for infusion vial	Has concentration strength numerator value	False	3	Inferred relationship	Some	1
Product containing precisely adenosine 6 milligram/2 milliliter conventional release solution for injection vial	Has concentration strength numerator value	False	3	Inferred relationship	Some	1

Page 1 of 5 Next End

Reference Sets

Concept inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
132068015	Three	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442100016	3 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442101017	3	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
7336651000172111	drie	nl	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Belgian module (core metadata concept)
7336661000172113	3	nl	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Belgian module (core metadata concept)